Advertisement

CardioVasc

, Volume 19, Issue 1, pp 39–44 | Cite as

Grenzwerte statt Korridore

Transatlantische Unterschiede bei den Hochdruckleitlinien

  • Markus van der GietEmail author
Fortbildung Schwerpunkt Hypertonie

Ein regelmäßig wiederkehrendes Ritual der letzten Jahrzehnte ist die Neubewertung der Blutdruckziele und Blutdrucktherapie. Die ersten Empfehlungen (JNC1) gab es Ende der 1970er-Jahre. 2017 und 2018 war es wieder soweit, die amerikanischen und europäischen Fachgesellschaften veröffentlichten ihre Hochdruckempfehlungen — mit unterschiedlichen Ergebnissen.

Literatur

  1. 1.
    Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104CrossRefGoogle Scholar
  2. 2.
    Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248CrossRefGoogle Scholar
  3. 3.
    Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72CrossRefGoogle Scholar
  4. 4.
    James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20CrossRefGoogle Scholar
  5. 5.
    Verdecchia P, Angeli F, Reboldi G. The SPRINT trial. J Am Soc Hypertens. 2015;9(10):750–3CrossRefGoogle Scholar
  6. 6.
    Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219CrossRefGoogle Scholar
  7. 7.
    Bauer F, Seibert FS, Rohn B et al. Attended Versus Unattended Blood Pressure Measurement in a Real Life Setting. Hypertension. 2018;71(2):243–9CrossRefGoogle Scholar
  8. 8.
    SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103–16CrossRefGoogle Scholar
  9. 9.
    Textor SC, Schwartz GL. BP Targets in CKD, Mortality, and SPRINT: What Have We Learned? J Am Soc Nephrol. 2017;28(9):2561–3CrossRefGoogle Scholar
  10. 10.
    Huang C, Dhruva SS, Coppi AC et al. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results. J Am Heart Assoc. 2017;6(11).  https://doi.org/10.1161/JAHA.117.007509
  11. 11.
    Ismail-Beigi F, Craven T, Banerji MA et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376(9739):419–30CrossRefGoogle Scholar
  12. 12.
    Myers MG, Godwin M, Dawes M et al. Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension. 2010;55(2):195–200CrossRefGoogle Scholar
  13. 13.
    Agarwal R. Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT). J Am Heart Assoc. 2017;6(2).  https://doi.org/10.1161/JAHA.116.004536

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Charité — Universitätsmedizin Berlin, Campus Benjamin Franklin, Med. Klinik mit SP Nephrologie HochdruckzentrumBerlinDeutschland

Personalised recommendations